113 related articles for article (PubMed ID: 16112587)
21. Iodine-123-iodobenzamide SPECT assessment of dopamine D2 receptor occupancy in riperidone-treated schizophrenic patients.
Dresel S; Tatsch K; Dähne I; Mager T; Scherer J; Hahn K
J Nucl Med; 1998 Jul; 39(7):1138-42. PubMed ID: 9669383
[TBL] [Abstract][Full Text] [Related]
22. Varenicline increases in vivo striatal dopamine D2/3 receptor binding: an ultra-high-resolution pinhole [123I]IBZM SPECT study in rats.
Crunelle CL; de Wit TC; de Bruin K; Ramakers RM; van der Have F; Beekman FJ; van den Brink W; Booij J
Nucl Med Biol; 2012 Jul; 39(5):640-4. PubMed ID: 22261145
[TBL] [Abstract][Full Text] [Related]
23. Striatal dopamine-2 receptor occupancy in psychotic patients treated with risperidone.
Küfferle B; Brücke T; Topitz-Schratzberger A; Tauscher J; Gössler R; Vesely C; Asenbaum S; Podreka I; Kasper S
Psychiatry Res; 1996 Nov; 68(1):23-30. PubMed ID: 9027930
[TBL] [Abstract][Full Text] [Related]
24. Striatal dopamine receptor binding in epileptic psychoses.
Ring HA; Trimble MR; Costa DC; Moriarty J; Verhoeff NP; Ell PJ
Biol Psychiatry; 1994 Mar; 35(6):375-80. PubMed ID: 8018783
[TBL] [Abstract][Full Text] [Related]
25. Striatal dopamine release after prefrontal repetitive transcranial magnetic stimulation in major depression: preliminary results of a dynamic [123I] IBZM SPECT study.
Pogarell O; Koch W; Pöpperl G; Tatsch K; Jakob F; Zwanzger P; Mulert C; Rupprecht R; Möller HJ; Hegerl U; Padberg F
J Psychiatr Res; 2006 Jun; 40(4):307-14. PubMed ID: 16259998
[TBL] [Abstract][Full Text] [Related]
26. A single photon emission computed tomography scan study of striatal dopamine D2 receptor binding with 123I-epidepride in patients with schizophrenia and controls.
Tibbo P; Silverstone PH; McEwan AJ; Scott J; Joshua A; Golberg K
J Psychiatry Neurosci; 1997 Jan; 22(1):39-45. PubMed ID: 9002391
[TBL] [Abstract][Full Text] [Related]
27. Loss of dopamine-D2 receptor binding sites in Parkinsonian plus syndromes.
Hierholzer J; Cordes M; Venz S; Schelosky L; Harisch C; Richter W; Keske U; Hosten N; Mäurer J; Poewe W; Felix R
J Nucl Med; 1998 Jun; 39(6):954-60. PubMed ID: 9627325
[TBL] [Abstract][Full Text] [Related]
28. Striatal amphetamine-induced dopamine release in patients with schizotypal personality disorder studied with single photon emission computed tomography and [123I]iodobenzamide.
Abi-Dargham A; Kegeles LS; Zea-Ponce Y; Mawlawi O; Martinez D; Mitropoulou V; O'Flynn K; Koenigsberg HW; Van Heertum R; Cooper T; Laruelle M; Siever LJ
Biol Psychiatry; 2004 May; 55(10):1001-6. PubMed ID: 15121484
[TBL] [Abstract][Full Text] [Related]
29. Pre-pulse inhibition and striatal dopamine in subjects at an ultra-high risk for psychosis.
De Koning MB; Bloemen OJ; Van Duin ED; Booij J; Abel KM; De Haan L; Linszen DH; Van Amelsvoort TA
J Psychopharmacol; 2014 Jun; 28(6):553-60. PubMed ID: 24526133
[TBL] [Abstract][Full Text] [Related]
30. Baseline and amphetamine-stimulated dopamine activity are related in drug-naïve schizophrenic subjects.
Abi-Dargham A; van de Giessen E; Slifstein M; Kegeles LS; Laruelle M
Biol Psychiatry; 2009 Jun; 65(12):1091-3. PubMed ID: 19167701
[TBL] [Abstract][Full Text] [Related]
31. The Effects of Antipsychotic Treatment on Presynaptic Dopamine Synthesis Capacity in First-Episode Psychosis: A Positron Emission Tomography Study.
Jauhar S; Veronese M; Nour MM; Rogdaki M; Hathway P; Natesan S; Turkheimer F; Stone J; Egerton A; McGuire P; Kapur S; Howes OD
Biol Psychiatry; 2019 Jan; 85(1):79-87. PubMed ID: 30122287
[TBL] [Abstract][Full Text] [Related]
32. Treadmill exercise elevates striatal dopamine D2 receptor binding potential in patients with early Parkinson's disease.
Fisher BE; Li Q; Nacca A; Salem GJ; Song J; Yip J; Hui JS; Jakowec MW; Petzinger GM
Neuroreport; 2013 Jul; 24(10):509-14. PubMed ID: 23636255
[TBL] [Abstract][Full Text] [Related]
33. The prognostic value of dopamine receptor occupancy by [123I]IBZM-SPECT in schizophrenic patients treated with quetiapine.
Pávics L; Szekeres G; Ambrus E; Kéri S; Kovács Z; Argyelán M; Kanyó B; Csernay L; Janka Z
Nucl Med Rev Cent East Eur; 2004; 7(2):129-33. PubMed ID: 15968599
[TBL] [Abstract][Full Text] [Related]
34. Reduced striatal D2 receptor binding in myoclonus-dystonia.
Beukers RJ; Booij J; Weisscher N; Zijlstra F; van Amelsvoort TA; Tijssen MA
Eur J Nucl Med Mol Imaging; 2009 Feb; 36(2):269-74. PubMed ID: 18719906
[TBL] [Abstract][Full Text] [Related]
35. In vivo measurement of haloperidol affinity to dopamine D2/D3 receptors by [123I]IBZM and single photon emission computed tomography.
Videbaek C; Toska K; Friberg L; Holm S; Angelo HR; Knudsen GM
J Cereb Blood Flow Metab; 2001 Jan; 21(1):92-7. PubMed ID: 11149673
[TBL] [Abstract][Full Text] [Related]
36. Striatal dopaminergic D(2) receptor density measured by [(123)I]iodobenzamide SPECT in the prediction of treatment outcome of alcohol-dependent patients.
Guardia J; Catafau AM; Batlle F; Martín JC; Segura L; Gonzalvo B; Prat G; Carrió I; Casas M
Am J Psychiatry; 2000 Jan; 157(1):127-9. PubMed ID: 10618027
[TBL] [Abstract][Full Text] [Related]
37. Stress-induced dopamine release in humans at risk of psychosis: a [11C]raclopride PET study.
Soliman A; O'Driscoll GA; Pruessner J; Holahan AL; Boileau I; Gagnon D; Dagher A
Neuropsychopharmacology; 2008 Jul; 33(8):2033-41. PubMed ID: 17957215
[TBL] [Abstract][Full Text] [Related]
38. Different striatal dopamine D2 receptor occupancy in alcohol dependent patients with or without physical withdrawal symptoms --a study using IBZM-SPECT.
Ebert D; Klein T; Lohrmann C; van Elst LT; Hesslinger B; Juengling FD
J Neural Transm (Vienna); 2002 Sep; 109(9):1215-9. PubMed ID: 12203049
[TBL] [Abstract][Full Text] [Related]
39. Stability of [123I]IBZM SPECT measurement of amphetamine-induced striatal dopamine release in humans.
Kegeles LS; Zea-Ponce Y; Abi-Dargham A; Rodenhiser J; Wang T; Weiss R; Van Heertum RL; Mann JJ; Laruelle M
Synapse; 1999 Mar; 31(4):302-8. PubMed ID: 10051112
[TBL] [Abstract][Full Text] [Related]
40. Increase of striatal dopamine transmission in first episode drug-naive schizophrenic patients as demonstrated by [(123)I]IBZM SPECT.
Schmitt GJ; Meisenzahl EM; Frodl T; La Fougère C; Hahn K; Möller HJ; Dresel S
Psychiatry Res; 2009 Sep; 173(3):183-9. PubMed ID: 19683898
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
